Daniel Koller
Chief Investment Officer presso BB BIOTECH AG
Profilo
Il Dr. Daniel Koller è Head BB Biotech di Bellevue Asset Management AG e Head-Investment Management di BB Biotech AG. È entrato in Bellevue Asset Management nel 2004 e dal 2010 dirige la gestione di BB Biotech AG. In precedenza è stato Head-Compliance presso Oz Holding AG, Private Equity Investor presso Equity4life AG, Equity Analyst presso UBS Warburg, Inc., Auditor presso Ernst & Young AG e Member-Management Board presso Patrimonium Swiss Real Estate Fund. Il Dr. Koller ha conseguito un master in biochimica presso il Politecnico federale di Zurigo e un dottorato in biotecnologia presso il Politecnico federale di Zurigo e la Cytos Biotechnology SA. Zurigo.
Posizioni attive di Daniel Koller
Società | Posizione | Inizio |
---|---|---|
BB BIOTECH AG | Chief Investment Officer | 01/01/2004 |
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Head-Equity Investments | 01/01/2010 |
Precedenti posizioni note di Daniel Koller
Società | Posizione | Fine |
---|---|---|
BELLEVUE GROUP AG | Director of Finance/CFO | 28/02/2019 |
VALARTIS GROUP AG | Compliance Officer | 01/01/2005 |
Equity4life AG | Corporate Officer/Principal | 01/01/2004 |
Ernst & Young AG
Ernst & Young AG Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AG is a Swiss company that provides accounting services. The private company is based in Zurich, Switzerland. | Corporate Officer/Principal | 01/01/2004 |
UBS Warburg, Inc. | Analyst-Equity | 31/12/2000 |
Formazione di Daniel Koller
Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BB BIOTECH AG | Finance |
VALARTIS GROUP AG | Finance |
BELLEVUE GROUP AG | Finance |
Aziende private | 5 |
---|---|
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
Equity4life AG | Miscellaneous |
Ernst & Young AG
Ernst & Young AG Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AG is a Swiss company that provides accounting services. The private company is based in Zurich, Switzerland. | Commercial Services |
UBS Warburg, Inc. | |
Patrimonium Swiss Real Estate Fund
Patrimonium Swiss Real Estate Fund Investment Trusts/Mutual FundsMiscellaneous Patrimonium Swiss Real Estate Fund operates as a closed-end investment fund. It invests in residential and mixed properties with a focus on residential properties in the moderate-rent segment, mainly in the Lake Geneva region and the Fribourg, Bern, Baser and Zug axis. The company was founded on November 20, 2007 and is headquartered in Crissier, Switzerland. | Miscellaneous |
- Borsa valori
- Insiders
- Daniel Koller